821 related articles for article (PubMed ID: 15224347)
1. Alterations in specific gene expression and focal neoplastic growth during spontaneous hepatocarcinogenesis in albumin-SV40 T antigen transgenic rats.
Dragan YP; Sargent LM; Babcock K; Kinunen N; Pitot HC
Mol Carcinog; 2004 Jul; 40(3):150-9. PubMed ID: 15224347
[TBL] [Abstract][Full Text] [Related]
2. Biallelic expression of the H19 gene during spontaneous hepatocarcinogenesis in the albumin SV40 T antigen transgenic rat.
Manoharan H; Babcock K; Willi J; Pitot HC
Mol Carcinog; 2003 Sep; 38(1):40-7. PubMed ID: 12949842
[TBL] [Abstract][Full Text] [Related]
3. Hepatocellular carcinomas of the albumin SV40 T-antigen transgenic rat display fetal-like re-expression of lgf2 and deregulation of H19.
Czarny MJ; Babcock K; Baus RM; Manoharan H; Pitot HC
Mol Carcinog; 2007 Sep; 46(9):747-57. PubMed ID: 17393425
[TBL] [Abstract][Full Text] [Related]
4. Specific chromosomal changes in albumin simian virus 40 T antigen transgenic rat liver neoplasms.
Sargent LM; Dragan YP; Sattler G; Xu YH; Wiley J; Pitot HC
Cancer Res; 1997 Aug; 57(16):3451-6. PubMed ID: 9270012
[TBL] [Abstract][Full Text] [Related]
5. Dual functions of E2F-1 in a transgenic mouse model of liver carcinogenesis.
Conner EA; Lemmer ER; Omori M; Wirth PJ; Factor VM; Thorgeirsson SS
Oncogene; 2000 Oct; 19(44):5054-62. PubMed ID: 11042693
[TBL] [Abstract][Full Text] [Related]
6. Changes in the DNA methylation profile of the rat H19 gene upstream region during development and transgenic hepatocarcinogenesis and its role in the imprinted transcriptional regulation of the H19 gene.
Manoharan H; Babcock K; Pitot HC
Mol Carcinog; 2004 Sep; 41(1):1-16. PubMed ID: 15352122
[TBL] [Abstract][Full Text] [Related]
7. Loss of heterozygosity of imprinted genes in SV40 t/T antigen-induced hepatocellular carcinomas.
Casola S; Ungaro P; Pedone PV; Lazzaro D; Fattori E; Ciliberto G; Zarrilli R; Bruni CB; Riccio A
Oncogene; 1995 Aug; 11(4):711-21. PubMed ID: 7651735
[TBL] [Abstract][Full Text] [Related]
8. Hepatocarcinogenesis in woodchuck hepatitis virus/c-myc mice: sustained cell proliferation and biphasic activation of insulin-like growth factor II.
Liu P; Terradillos O; Renard CA; Feldmann G; Buendia MA; Bernuau D
Hepatology; 1997 Apr; 25(4):874-83. PubMed ID: 9096591
[TBL] [Abstract][Full Text] [Related]
9. Cell cycle deregulation in liver lesions of rats with and without genetic predisposition to hepatocarcinogenesis.
Pascale RM; Simile MM; De Miglio MR; Muroni MR; Calvisi DF; Asara G; Casabona D; Frau M; Seddaiu MA; Feo F
Hepatology; 2002 Jun; 35(6):1341-50. PubMed ID: 12029619
[TBL] [Abstract][Full Text] [Related]
10. Evolution of neoplastic development in the liver of transgenic mice co-expressing c-myc and transforming growth factor-alpha.
Santoni-Rugiu E; Nagy P; Jensen MR; Factor VM; Thorgeirsson SS
Am J Pathol; 1996 Aug; 149(2):407-28. PubMed ID: 8701981
[TBL] [Abstract][Full Text] [Related]
11. Coordinate expression of N-myc 2 and insulin-like growth factor II in precancerous altered hepatic foci in woodchuck hepatitis virus carriers.
Yang D; Alt E; Rogler CE
Cancer Res; 1993 May; 53(9):2020-7. PubMed ID: 8481904
[TBL] [Abstract][Full Text] [Related]
12. Changes in the antioxidant defense and hepatic drug metabolizing enzyme and isoenzyme levels, 8-hydroxydeoxyguanosine formation and expressions of c-raf.1 and insulin-like growth factor II genes during the stages of development of hepatocellular carcinoma in rats.
Mukherjee B; Das T; Ghosh S; Datta S
Eur J Cancer Prev; 2007 Aug; 16(4):363-71. PubMed ID: 17554210
[TBL] [Abstract][Full Text] [Related]
13. Insulin-like growth factor II regulation of gene expression in rat and human hepatomas.
Zvibel I; Brill S; Reid LM
J Cell Physiol; 1995 Jan; 162(1):36-43. PubMed ID: 7529237
[TBL] [Abstract][Full Text] [Related]
14. Cytogenetic analysis of three rat liver epithelial cell lines (WBneo, WBHa-ras, and WBrasIIa) and correlation of an early chromosomal alteration with insulin-like growth factor II expression.
Sargent L; Dragan YP; Babcock K; Wiley J; Klaunig J; Pitot HC
Cancer Res; 1996 Jul; 56(13):2992-7. PubMed ID: 8674053
[TBL] [Abstract][Full Text] [Related]
15. Ploidy and karyotypic alterations associated with early events in the development of hepatocarcinogenesis in transgenic mice harboring c-myc and transforming growth factor alpha transgenes.
Sargent LM; Sanderson ND; Thorgeirsson SS
Cancer Res; 1996 May; 56(9):2137-42. PubMed ID: 8616862
[TBL] [Abstract][Full Text] [Related]
16. Development of a transgenic mouse system for the analysis of stages in liver carcinogenesis using tissue-specific expression of SV40 large T-antigen controlled by regulatory elements of the human alpha-1-antitrypsin gene.
Sepulveda AR; Finegold MJ; Smith B; Slagle BL; DeMayo JL; Shen RF; Woo SL; Butel JS
Cancer Res; 1989 Nov; 49(21):6108-17. PubMed ID: 2551499
[TBL] [Abstract][Full Text] [Related]
17. Correlation of c-myc overexpression and amplification with progression of preneoplastic liver lesions to malignancy in the poorly susceptible Wistar rat strain.
De Miglio MR; Simile MM; Muroni MR; Pusceddu S; Calvisi D; Carru A; Seddaiu MA; Daino L; Deiana L; Pascale RM; Feo F
Mol Carcinog; 1999 May; 25(1):21-9. PubMed ID: 10331741
[TBL] [Abstract][Full Text] [Related]
18. The c-Myc oncogene directly induces the H19 noncoding RNA by allele-specific binding to potentiate tumorigenesis.
Barsyte-Lovejoy D; Lau SK; Boutros PC; Khosravi F; Jurisica I; Andrulis IL; Tsao MS; Penn LZ
Cancer Res; 2006 May; 66(10):5330-7. PubMed ID: 16707459
[TBL] [Abstract][Full Text] [Related]
19. Cell lines with heterogeneous phenotypes result from a single isolation of albumin-sv40 T-antigen transgenic rat hepatocytes.
Bulera SJ; Haas MJ; Sattler CA; Li Y; Pitot HC
Hepatology; 1997 May; 25(5):1192-203. PubMed ID: 9141438
[TBL] [Abstract][Full Text] [Related]
20. PEG10 is a c-MYC target gene in cancer cells.
Li CM; Margolin AA; Salas M; Memeo L; Mansukhani M; Hibshoosh H; Szabolcs M; Klinakis A; Tycko B
Cancer Res; 2006 Jan; 66(2):665-72. PubMed ID: 16423995
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
